In addition to caspase, linkers that can respond to legumain, a biomarker overexpressed in several cancers such as breast cancer, gastric cancer, colorectal cancer, have been developed for PET imaging of legumain activity and diagnosis of legumain‐related diseases. This evidence concerns the gene LGMN and breast cancer.